Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus

Choul Yong Park, Roy S. Chuck, Marisol Cano, Margaret Yew, Viet Nguyen, Jack Parker, Keisuke Mori, Peter L. Gehlbach

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

PURPOSE. A noninvasive imaging technique was used for serial assessment of gene expression after intraocular gene transfer. Bioluminescence after intravitreous administration of an adenovirus vector containing the firefly luciferase gene was measured serially and noninvasively. The optical signal was then used as a bioassay to determine whether periocular immune modulation affects intraocular transgene expression. METHODS. Sixty-two, 8-week-old, male BALB/c mice were used. The correlation of optical signal intensity was determined by tissue luciferase level after injecting 30 mice with one of three intravitreous doses of Ad-Luc-GFP (108, 5 × 108, or 109 particles in 1 μL). Ocular bioluminescence was measured at days 2, 5, 8, and 14. The bioluminescence was then directly compared with measured tissue luciferase levels. The remaining 32 mice were divided into two groups. One group (n = 16), was injected with periocular corticosteroid (400 μg in 10 μL). Two days later, Ad-Luc-GFP was administered by intravitreous injection (109 particles in 1 μL). The remaining mice (n = 16) were injected with the same dose of intravitreous Ad-Luc-GFP without corticosteroid pretreatment. Ocular bioluminescence was then assessed longitudinally on days 2, 4, 6, 8, 11, 14, 22, and 30 after intravitreous injection in n = 10 mice per group. The optical signal intensity in each group was compared over the study period. The remaining 12 mice (n = 6, each group) were used to assess histologic differences between the two groups. RESULTS. In vivo measurement of ocular bioluminescence was well correlated with tissue luciferase levels (Spearman's correlation, r = 0.969, P < 0.001). Periocular TA injection markedly decreased the acute inflammatory reaction associated with intravitreous Ad-Luc-GFP and was associated with a significant increase in the duration of peak luciferase expression as well as the total period of luciferase expression. CONCLUSIONS. A significant enhancement of intraocular transgene expression is associated with periocular pretreatment with corticosteroid. Histologic evidence of immune cell reduction in ocular tissues in corticosteroid-treated eyes implies a local immune response. Periocular treatment with corticosteroids may enhance adenovirus-mediated gene expression in the eye.

Original languageEnglish (US)
Pages (from-to)399-406
Number of pages8
JournalInvestigative Ophthalmology and Visual Science
Volume49
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Triamcinolone
Adenoviridae
Luciferases
Adrenal Cortex Hormones
Gene Expression
Transgenes
Intraocular Injections
Luminescent Measurements
Firefly Luciferases
Injections
Biological Assay
Genes

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus. / Park, Choul Yong; Chuck, Roy S.; Cano, Marisol; Yew, Margaret; Nguyen, Viet; Parker, Jack; Mori, Keisuke; Gehlbach, Peter L.

In: Investigative Ophthalmology and Visual Science, Vol. 49, No. 1, 01.2008, p. 399-406.

Research output: Contribution to journalArticle

Park, Choul Yong ; Chuck, Roy S. ; Cano, Marisol ; Yew, Margaret ; Nguyen, Viet ; Parker, Jack ; Mori, Keisuke ; Gehlbach, Peter L. / Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus. In: Investigative Ophthalmology and Visual Science. 2008 ; Vol. 49, No. 1. pp. 399-406.
@article{e4d6c2e6bc884bb9a27161702db6ceae,
title = "Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus",
abstract = "PURPOSE. A noninvasive imaging technique was used for serial assessment of gene expression after intraocular gene transfer. Bioluminescence after intravitreous administration of an adenovirus vector containing the firefly luciferase gene was measured serially and noninvasively. The optical signal was then used as a bioassay to determine whether periocular immune modulation affects intraocular transgene expression. METHODS. Sixty-two, 8-week-old, male BALB/c mice were used. The correlation of optical signal intensity was determined by tissue luciferase level after injecting 30 mice with one of three intravitreous doses of Ad-Luc-GFP (108, 5 × 108, or 109 particles in 1 μL). Ocular bioluminescence was measured at days 2, 5, 8, and 14. The bioluminescence was then directly compared with measured tissue luciferase levels. The remaining 32 mice were divided into two groups. One group (n = 16), was injected with periocular corticosteroid (400 μg in 10 μL). Two days later, Ad-Luc-GFP was administered by intravitreous injection (109 particles in 1 μL). The remaining mice (n = 16) were injected with the same dose of intravitreous Ad-Luc-GFP without corticosteroid pretreatment. Ocular bioluminescence was then assessed longitudinally on days 2, 4, 6, 8, 11, 14, 22, and 30 after intravitreous injection in n = 10 mice per group. The optical signal intensity in each group was compared over the study period. The remaining 12 mice (n = 6, each group) were used to assess histologic differences between the two groups. RESULTS. In vivo measurement of ocular bioluminescence was well correlated with tissue luciferase levels (Spearman's correlation, r = 0.969, P < 0.001). Periocular TA injection markedly decreased the acute inflammatory reaction associated with intravitreous Ad-Luc-GFP and was associated with a significant increase in the duration of peak luciferase expression as well as the total period of luciferase expression. CONCLUSIONS. A significant enhancement of intraocular transgene expression is associated with periocular pretreatment with corticosteroid. Histologic evidence of immune cell reduction in ocular tissues in corticosteroid-treated eyes implies a local immune response. Periocular treatment with corticosteroids may enhance adenovirus-mediated gene expression in the eye.",
author = "Park, {Choul Yong} and Chuck, {Roy S.} and Marisol Cano and Margaret Yew and Viet Nguyen and Jack Parker and Keisuke Mori and Gehlbach, {Peter L.}",
year = "2008",
month = "1",
doi = "10.1167/iovs.07-0619",
language = "English (US)",
volume = "49",
pages = "399--406",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "1",

}

TY - JOUR

T1 - Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus

AU - Park, Choul Yong

AU - Chuck, Roy S.

AU - Cano, Marisol

AU - Yew, Margaret

AU - Nguyen, Viet

AU - Parker, Jack

AU - Mori, Keisuke

AU - Gehlbach, Peter L.

PY - 2008/1

Y1 - 2008/1

N2 - PURPOSE. A noninvasive imaging technique was used for serial assessment of gene expression after intraocular gene transfer. Bioluminescence after intravitreous administration of an adenovirus vector containing the firefly luciferase gene was measured serially and noninvasively. The optical signal was then used as a bioassay to determine whether periocular immune modulation affects intraocular transgene expression. METHODS. Sixty-two, 8-week-old, male BALB/c mice were used. The correlation of optical signal intensity was determined by tissue luciferase level after injecting 30 mice with one of three intravitreous doses of Ad-Luc-GFP (108, 5 × 108, or 109 particles in 1 μL). Ocular bioluminescence was measured at days 2, 5, 8, and 14. The bioluminescence was then directly compared with measured tissue luciferase levels. The remaining 32 mice were divided into two groups. One group (n = 16), was injected with periocular corticosteroid (400 μg in 10 μL). Two days later, Ad-Luc-GFP was administered by intravitreous injection (109 particles in 1 μL). The remaining mice (n = 16) were injected with the same dose of intravitreous Ad-Luc-GFP without corticosteroid pretreatment. Ocular bioluminescence was then assessed longitudinally on days 2, 4, 6, 8, 11, 14, 22, and 30 after intravitreous injection in n = 10 mice per group. The optical signal intensity in each group was compared over the study period. The remaining 12 mice (n = 6, each group) were used to assess histologic differences between the two groups. RESULTS. In vivo measurement of ocular bioluminescence was well correlated with tissue luciferase levels (Spearman's correlation, r = 0.969, P < 0.001). Periocular TA injection markedly decreased the acute inflammatory reaction associated with intravitreous Ad-Luc-GFP and was associated with a significant increase in the duration of peak luciferase expression as well as the total period of luciferase expression. CONCLUSIONS. A significant enhancement of intraocular transgene expression is associated with periocular pretreatment with corticosteroid. Histologic evidence of immune cell reduction in ocular tissues in corticosteroid-treated eyes implies a local immune response. Periocular treatment with corticosteroids may enhance adenovirus-mediated gene expression in the eye.

AB - PURPOSE. A noninvasive imaging technique was used for serial assessment of gene expression after intraocular gene transfer. Bioluminescence after intravitreous administration of an adenovirus vector containing the firefly luciferase gene was measured serially and noninvasively. The optical signal was then used as a bioassay to determine whether periocular immune modulation affects intraocular transgene expression. METHODS. Sixty-two, 8-week-old, male BALB/c mice were used. The correlation of optical signal intensity was determined by tissue luciferase level after injecting 30 mice with one of three intravitreous doses of Ad-Luc-GFP (108, 5 × 108, or 109 particles in 1 μL). Ocular bioluminescence was measured at days 2, 5, 8, and 14. The bioluminescence was then directly compared with measured tissue luciferase levels. The remaining 32 mice were divided into two groups. One group (n = 16), was injected with periocular corticosteroid (400 μg in 10 μL). Two days later, Ad-Luc-GFP was administered by intravitreous injection (109 particles in 1 μL). The remaining mice (n = 16) were injected with the same dose of intravitreous Ad-Luc-GFP without corticosteroid pretreatment. Ocular bioluminescence was then assessed longitudinally on days 2, 4, 6, 8, 11, 14, 22, and 30 after intravitreous injection in n = 10 mice per group. The optical signal intensity in each group was compared over the study period. The remaining 12 mice (n = 6, each group) were used to assess histologic differences between the two groups. RESULTS. In vivo measurement of ocular bioluminescence was well correlated with tissue luciferase levels (Spearman's correlation, r = 0.969, P < 0.001). Periocular TA injection markedly decreased the acute inflammatory reaction associated with intravitreous Ad-Luc-GFP and was associated with a significant increase in the duration of peak luciferase expression as well as the total period of luciferase expression. CONCLUSIONS. A significant enhancement of intraocular transgene expression is associated with periocular pretreatment with corticosteroid. Histologic evidence of immune cell reduction in ocular tissues in corticosteroid-treated eyes implies a local immune response. Periocular treatment with corticosteroids may enhance adenovirus-mediated gene expression in the eye.

UR - http://www.scopus.com/inward/record.url?scp=39549088377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39549088377&partnerID=8YFLogxK

U2 - 10.1167/iovs.07-0619

DO - 10.1167/iovs.07-0619

M3 - Article

C2 - 18172118

AN - SCOPUS:39549088377

VL - 49

SP - 399

EP - 406

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 1

ER -